πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8114406

Peptides and their utility in modulation of behavior of cells expressing Ξ±3Ξ²1 integrins

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8110352

Method of diagnosing and treating cancer using B-catenin splice variants

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8110681

Compounds for the treatment of spinal muscular atrophy and other uses

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8110354

Use of Shigella invaplex to transport functional proteins and transcriptionally active nuc

The United States of America as represented by the Secretary of the Army Β· Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8110192

Human immunodeficiency virus type 1 (HIV-1)-neutralizing human single-chain antibodies wit

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8105609

Flavivirus immunogens comprising extracellular viral particles composed of the premembrane

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8106027

Development of a preventive vaccine for filovirus infection in primates

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8106026

Development of a preventive vaccine for filovirus infection in primates

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8106006

Modified defensins and their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8105598

Human monoclonal antibodies that specifically bind IGF-II

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8101380

Schizophrenia-related isoform of KCNH2 and development of antipsychotic drugs

The United States of America, as represented by the Secretary, Health and Human Services Β· Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8101739

Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) ang

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8101172

Solenopsis invicta virus

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8092988

Medium and method of deriving and using a mutated bacteria strain

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8093343

Nitric oxide-releasing diazeniumdiolated compounds

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8092809

Pseudomonas exotoxin A-like chimeric immunogens

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8088388

Stabilized synthetic immunogen delivery system

United Biomedical, Inc. Β· Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8088787

Methods related to the treatment of neurodegenerative and inflammatory conditions

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8088729

Anti-viral griffithsin compounds, compositions and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8088379

Modified T cell receptors and related materials and methods

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8084594

H2N3 influenza A viruses and methods of use

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8084415

Uteroglobin in the treatment of IGA mediated nephropathy

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8084250

Defensin-antigen fusion proteins

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8084199

Method of diagnosing poor survival prognosis colon cancer using microRNA-21

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH Β· Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted